The Rh marker on your red blood cells matters during pregnancy because a mismatch between your blood type and your baby’s can trigger your immune system to attack the baby’s red blood cells. About 15% of women in the United States are Rh-negative, meaning they lack a specific protein (called the D antigen) on the surface of their red blood cells. If the baby inherits Rh-positive blood from the father, the mother’s body can treat those fetal blood cells as foreign invaders.
This immune reaction doesn’t usually cause problems in a first pregnancy, but it can become dangerous in later ones. The good news: routine blood testing and a widely available preventive treatment have made serious complications rare in countries with modern prenatal care.
How Rh Incompatibility Develops
During pregnancy and especially during delivery, small amounts of fetal blood can cross into the mother’s bloodstream. If the mother is Rh-negative and the baby is Rh-positive, her immune system recognizes the D antigen on those fetal cells as something that doesn’t belong. The first time this happens, her body produces large antibodies that can’t cross the placenta, so the baby is typically unharmed.
The problem starts with the next Rh-positive pregnancy. The mother’s immune system now “remembers” the D antigen and mounts a fast, aggressive response, producing smaller antibodies that do cross the placenta. These antibodies latch onto the baby’s red blood cells and mark them for destruction. Each subsequent pregnancy with an Rh-positive baby tends to produce a stronger immune response, meaning the risk increases with every pregnancy.
Blood mixing between mother and baby can happen during delivery, but it also occurs after miscarriage, ectopic pregnancy, amniocentesis, abdominal trauma from a fall or car accident, or manual procedures during labor. Notably, about 82% of fetal-to-maternal blood transfers happen spontaneously with no identifiable cause, which is why screening every pregnant person is standard practice rather than waiting for a triggering event.
What Happens to the Baby
When maternal antibodies destroy fetal red blood cells, the condition is called hemolytic disease of the newborn. The severity ranges widely depending on how many antibodies are crossing the placenta.
In mild cases, the baby develops anemia and a buildup of bilirubin, a yellow-pigmented waste product released when red blood cells break down. Babies can’t clear bilirubin efficiently, so it accumulates in the blood and tissues, causing jaundice (yellowing of the skin and eyes). Mild jaundice is treatable and common even in babies without Rh problems, but at high levels, bilirubin can damage the brain.
In severe cases, the baby’s liver and spleen enlarge as they work overtime to replace destroyed blood cells. The most dangerous outcome is hydrops fetalis, where the baby’s organs can no longer compensate for the anemia. The heart begins to fail, and fluid accumulates throughout the body. A baby with hydrops is at serious risk of stillbirth. Babies who survive may be born extremely pale and swollen, often with breathing difficulties.
Why Later Pregnancies Carry Higher Risk
A first affected pregnancy tends to be milder because the mother’s antibody levels start low and may not rise significantly until late in the second or third trimester. The baby’s anemia, if it develops at all, often appears late enough that the pregnancy can be managed without major intervention.
In subsequent pregnancies, the pattern changes. The immune response kicks in earlier and hits harder. Fetal anemia can develop sooner in gestation, and maternal antibody levels are no longer a reliable way to predict how severely the baby is affected. Instead, doctors rely on specialized ultrasound measurements of blood flow in the baby’s brain to detect anemia in real time. The earlier and more severe the anemia, the more likely the baby will need treatment before birth, such as a blood transfusion delivered through the umbilical cord.
How Your Rh Status Is Tested
Every pregnant person gets a blood test at the first prenatal visit, typically around 12 weeks. This test determines two things: your ABO blood type (A, B, AB, or O) and your Rh status (positive or negative). At the same time, the lab runs an antibody screen to check whether your blood already contains antibodies against Rh or other red blood cell proteins.
If you’re Rh-negative and the antibody screen is negative, you haven’t been sensitized yet, and the focus shifts to prevention. If antibodies are already present, the pregnancy is monitored more closely. Antibody levels at or below 1:8 (a measure of concentration) can generally be tracked with repeat blood tests. Once levels reach 1:16 or higher, more intensive monitoring of the baby begins.
Determining the Baby’s Rh Status
A newer option allows doctors to determine the baby’s Rh type from a simple maternal blood draw, using fragments of fetal DNA that circulate in the mother’s bloodstream. A U.S. study of 401 Rh-negative pregnant women found that this test was 100% accurate when compared with the baby’s blood type after birth, with no false positives or false negatives across a racially and ethnically diverse group. If the test shows the baby is Rh-negative, there’s no mismatch and no risk, which means the mother can skip preventive treatment entirely.
How Rh Problems Are Prevented
The standard prevention is an injection of Rh immune globulin, a blood product that neutralizes any fetal Rh-positive cells in the mother’s bloodstream before her immune system can react to them. This effectively stops sensitization from ever starting.
For Rh-negative mothers who haven’t been sensitized, the injection is typically given around 28 weeks of pregnancy and again within 72 hours after delivery if the baby turns out to be Rh-positive. It’s also given after any event that could cause blood mixing: miscarriage, ectopic pregnancy, amniocentesis, or significant abdominal trauma.
The injection only works as prevention. Once a mother’s immune system has already been sensitized and is producing its own antibodies against Rh-positive blood, the treatment can no longer reverse the process. That’s why early and consistent screening matters so much. Missing the window for prevention means every future Rh-positive pregnancy carries escalating risk.
What This Means If You’re Rh-Negative
Being Rh-negative is not itself a problem. It only becomes relevant if your baby is Rh-positive, which depends on the father’s blood type. If both parents are Rh-negative, every baby will be Rh-negative, and there’s no risk of incompatibility at all.
If the father is Rh-positive (which is the majority of the population), the baby has a high chance of being Rh-positive as well, since the Rh-positive trait is genetically dominant. In that scenario, the preventive injection is straightforward, well-established, and highly effective at keeping both the current and future pregnancies safe. The key is knowing your Rh status early, which is exactly why it’s one of the first things tested in prenatal care.